Genelux (GNLX) Tax Provisions (2022)

Genelux (GNLX) posted quarterly Tax Provisions of $1.1 million for Q3 2022.

Genelux (GNLX) Tax Provisions (2022) Analysis & Trends

Genelux's Tax Provisions history runs 1 years deep, the most recent figure standing at $1.1 million for Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	292.00 Mn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	230.90 Mn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	59.00 Mn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	15.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	75.45 Mn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	13.31 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	1.90 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	-90.33 Mn
10	Genelux	120.53 Mn	120.53 Mn	-	-

Download Data

Date	Value
Sep 30, 2022	1.10 Mn